公开(公告)号：EP3508474A1

公开(公告)日：2019-07-10

申请号：EP17846404.6

申请日：2017-08-28

申请人： JCR Pharmaceuticals Co., Ltd. ,  National University Corporation Kobe University ,  National University Corporation Chiba University

发明人： SEINO, Susumu ,  SUGAWARA, Kenji ,  MORI, Ichiro ,  MATSUMOTO, Akio ,  REIEN, Yoshie

IPC分类号： C07C281/06 ,  A61K31/17 ,  A61K31/175 ,  A61P3/10 ,  C07C337/06

摘要： A nobel therapeutic agent for diabetes which can suppress occurrence of side effects such as persistent hypoglycemia is provided. The active ingredient is a derivative of 1,1-diphenylsemicarbazide or 1,1-diphenylthiosemicarbazide. In particular, the active ingredient is a derivative of 1,1-diphenyl-4-cyclohexyl-semicarbazide or 1,1-diphenyl-4-cyclohexyl-thiosemicarbazide exhibiting hypoglycemic action when orally administered.